141 related articles for article (PubMed ID: 35369117)
21. Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma.
Henckens SPG; Liu D; Gisbertz SS; Kalff MC; Anderegg MCJ; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; van Duijvendijk P; Eshuis WJ; Groenendijk RPR; Haveman JW; van Hillegersberg R; Luyer MDP; Olthof PB; Pierie JEN; Plat VD; Rosman C; Ruurda JP; van Sandick JW; Sosef MN; Voeten DM; Vijgen GHEJ; Bijlsma MF; Meijer SL; Hulshof MCCM; Oyarce C; Lagarde SM; van Laarhoven HWM; van Berge Henegouwen MI;
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38387083
[TBL] [Abstract][Full Text] [Related]
22. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
[TBL] [Abstract][Full Text] [Related]
23. Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
De la Cruz-Ku GA; Chambergo-Michilot D; Valcarcel B; Rebaza P; Möller M; Araujo JM; Enriquez D; Morante Z; Razuri C; Luque R; Saavedra A; Eyzaguirre E; Lujan M; Noel N; Pinto J; Cotrina J; Gomez H
Breast J; 2020 Sep; 26(9):1659-1666. PubMed ID: 32713113
[TBL] [Abstract][Full Text] [Related]
24. [Impact of stages of axillary lymph nodes and pathological response to neoadjuvant chemotherapy on the survival of breast cancer patients].
Wang W; Zhang B; Xu X; Wang X; Zhang P; Wang X
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):195-9. PubMed ID: 25975788
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
26. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
28. Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.
Hölscher AH; Drebber U; Schmidt H; Bollschweiler E
Ann Surg; 2014 Nov; 260(5):779-84; discussion 784-5. PubMed ID: 25379849
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
30. [Impact of response of primary tumor and positive axillary lymph node to neoadjuvant chemotherapy on breast cancer survival].
Wang X; He Y; Li J; Xie Y; Wang T; Fan Z; Fan T; Ouyang T
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(4):256-9. PubMed ID: 25877239
[TBL] [Abstract][Full Text] [Related]
31. Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment.
Meng F; Yang Y; Wang X; Cai F; Liang H; Zhang R; Deng J
Surgery; 2023 Oct; 174(4):836-843. PubMed ID: 37562986
[TBL] [Abstract][Full Text] [Related]
32. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
33. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
34. Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer.
Zhang GC; Zhang YF; Xu FP; Qian XK; Guo ZB; Ren CY; Yao M
Curr Oncol; 2013 Jun; 20(3):e180-92. PubMed ID: 23737688
[TBL] [Abstract][Full Text] [Related]
35. Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.
Fukada I; Araki K; Kobayashi K; Shibayama T; Takahashi S; Horii R; Akiyama F; Iwase T; Ohno S; Hatake K; Hozumi Y; Sata N; Ito Y
PLoS One; 2016; 11(9):e0162616. PubMed ID: 27631393
[TBL] [Abstract][Full Text] [Related]
36. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
37. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemoradiation treatment followed by surgery for esophageal cancer: there is much more than the mandard tumor regression score.
Depypere L; Moons J; Lerut T; De Hertogh G; Sagaert X; Coosemans W; Van Veer H; Renders A; Nafteux P
Acta Chir Belg; 2016 Jun; 116(3):149-155. PubMed ID: 27472306
[TBL] [Abstract][Full Text] [Related]
39. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
40. [The significance of lymph node yield in rectal cancer after neoadjuvant chemotherapy].
Zhu LY; Gao ZD; Ye YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):896-900. PubMed ID: 31550831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
